These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19353726)

  • 1. Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.
    Stamelou M; Matusch A; Elmenhorst D; Hurlemann R; Eggert KM; Zilles K; Oertel WH; Höglinger GU; Bauer A
    Mov Disord; 2009 Jun; 24(8):1170-5. PubMed ID: 19353726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
    Ma JH; Dong C; Qiao HW; Barret O; Tamagnan GD; Mao W; Xu EH; Zhang C; Lu J; Chan P; Liu SY
    Mov Disord; 2024 May; 39(5):847-854. PubMed ID: 38477228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
    Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
    Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
    Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
    Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
    Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy.
    Lewerenz J; Zurowski B; Jenicke L; Bäumer T; Lees AJ; Münchau A
    Mov Disord; 2005 Aug; 20(8):1071-5. PubMed ID: 15838851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
    Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
    Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
    Cordes M; Snow BJ; Morrison S; Sossi V; Ruth TJ; Calne DB
    Neuroradiology; 1993; 35(6):404-9. PubMed ID: 8377907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
    Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
    Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
    Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease.
    Hornykiewicz O; Shannak K
    J Neural Transm Suppl; 1994; 42():219-27. PubMed ID: 7964689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.